Skip to main content
    V

    Viridian Therapeutics Inc (VRDN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $30.06
    +0.26 (+0.87%)

    Market Cap: $3.51B

    Last updated: Nov 17, 2026 at 4:14 PM ET

    Viridian Therapeutics Inc (VRDN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Viridian Therapeutics (VRDN) has a latest price of $30.06 on Nov 17, 2026, 12.3% below its 52-week high of $34.29. Its price rose 4.5% over the past 12 months. The month-end price fell 69.5% over the 10 years through Oct 2026, a compound annual decline of 11.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $205.10 in Jul 2017 and its lowest $6.69 in Mar 2020, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VRDN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VRDN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 21.2%, and over 6 months it rose 88.2%. The month-end price rose 97.4% over the 3 years through Oct 2026, a compound annual rate of 25.4%.

    PeriodChange
    1 month+44.5%
    3 months+21.2%
    6 months+88.2%
    12 months+4.5%
    12 months, with dividends+4.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+97.4%+25.4%
    5 years+36.3%+6.4%
    10 years-69.5%-11.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 128.6%, and its weakest was 2019, when it fell 84.2%.

    YearCloseChange
    2026 through Oct 2026$24.67-20.7%
    2025$31.12+62.3%
    2024$19.17-12.0%
    2023$21.78-25.4%
    2022$29.21+47.7%
    2021$19.77+20.2%
    2020$16.45+128.6%
    2019$7.20-84.2%
    2018$45.43-70.9%
    2017$156.37+108.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 30.6% above its 50-day average of $23.02 and 39.7% above its 200-day average of $21.52.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$30.06
    52-week high$34.29-12.3%
    52-week low$13.18+128.1%
    50-day average$23.02+30.6%
    200-day average$21.52+39.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 60.6%.

    MeasureValue
    1-year beta1.11
    Largest fall, 1 year-60.6%
    Largest fall, 3 years-60.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VRDN

    What is VRDN's 1-year price change?

    Viridian Therapeutics's price rose 4.5% over the past 12 months. With dividends included, the 12-month total return was 4.5%.

    What is VRDN's 5-year price change?

    Viridian Therapeutics's month-end price rose 36.3% over the 5 years through Oct 2026, a compound annual rate of 6.4%. These figures leave out dividends.

    What is VRDN's 52-week high and low?

    Viridian Therapeutics's 52-week high is $34.29 and its 52-week low is $13.18. Its latest price of $30.06 on Nov 17, 2026 is 12.3% below the high.

    What is VRDN's beta?

    Viridian Therapeutics's 1-year beta against the S&P 500 is 1.11, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 60.6%.

    Is the VRDN chart free?

    Yes. Advanced Charting for VRDN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.